1. Home
  2. CURB vs NUWE Comparison

CURB vs NUWE Comparison

Compare CURB & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CURB
  • NUWE
  • Stock Information
  • Founded
  • CURB 2024
  • NUWE 1999
  • Country
  • CURB United States
  • NUWE United States
  • Employees
  • CURB N/A
  • NUWE N/A
  • Industry
  • CURB
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CURB
  • NUWE Health Care
  • Exchange
  • CURB NYSE
  • NUWE Nasdaq
  • Market Cap
  • CURB N/A
  • NUWE 3.9M
  • IPO Year
  • CURB N/A
  • NUWE N/A
  • Fundamental
  • Price
  • CURB $23.39
  • NUWE $0.98
  • Analyst Decision
  • CURB Buy
  • NUWE Strong Buy
  • Analyst Count
  • CURB 7
  • NUWE 1
  • Target Price
  • CURB $26.29
  • NUWE $17.00
  • AVG Volume (30 Days)
  • CURB 635.6K
  • NUWE 55.0K
  • Earning Date
  • CURB 04-24-2025
  • NUWE 05-13-2025
  • Dividend Yield
  • CURB 1.75%
  • NUWE N/A
  • EPS Growth
  • CURB N/A
  • NUWE N/A
  • EPS
  • CURB 0.11
  • NUWE N/A
  • Revenue
  • CURB $131,537,000.00
  • NUWE $8,740,000.00
  • Revenue This Year
  • CURB $24.92
  • NUWE $22.96
  • Revenue Next Year
  • CURB $16.33
  • NUWE $29.97
  • P/E Ratio
  • CURB $212.31
  • NUWE N/A
  • Revenue Growth
  • CURB 31.90
  • NUWE N/A
  • 52 Week Low
  • CURB $18.80
  • NUWE $0.75
  • 52 Week High
  • CURB $25.69
  • NUWE $11.55
  • Technical
  • Relative Strength Index (RSI)
  • CURB N/A
  • NUWE 50.79
  • Support Level
  • CURB N/A
  • NUWE $0.89
  • Resistance Level
  • CURB N/A
  • NUWE $1.00
  • Average True Range (ATR)
  • CURB 0.00
  • NUWE 0.08
  • MACD
  • CURB 0.00
  • NUWE 0.01
  • Stochastic Oscillator
  • CURB 0.00
  • NUWE 55.73

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: